|
|
| Phases of Development | Preclinical | Phase I/II | Phase II | Phase II/III | Phase III | Registration | Approved | Marketed |
|---|
| Autoimmune | 0 | 0 | 2 | 0 | 0 | 1 | 0 | 5 | | Cancer | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | | Infectious | 3 | 1 | 5 | 1 | 1 | 0 | 2 | 8 | | Inflammation | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Pulmonary | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Type I interferon (IFN) receptor